
Reliable Global Supply of Breztri Aerosphere Inhalation for Hospitals, Clinics & Distributors
Cordium Pharmaceuticals Pvt Ltd, a trusted pharmaceutical exporter from India, provides global sourcing support and export solutions for Breztri Aerosphere Inhaler for healthcare providers, pharmacies, hospitals, and distributors across international markets.
Breztri Aerosphere Inhaler Composition:
Budesonide + Glycopyrrolate + Formoterol Fumarate inhalation aerosol (Triple Therapy)
Breztri Aerosphere Inhaler Uses & Therapeutic Benefits
Breztri Aerosphere is a respiratory inhalation therapy used in the management of chronic respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease).
Key Advantages:
β’ Helps improve airflow and breathing comfort
β’ Supports long-term COPD maintenance therapy
β’ Triple-action inhaler formulation
β’ Helps reduce respiratory symptoms like breathlessness and wheezing
β’ Convenient inhalation delivery system
Note: Use only under healthcare professional guidance and as per approved prescribing information.
Global Export Markets & Demand Locations
Cordium Pharmaceuticals Pvt Ltd supports supply enquiries from:
πΊπΈ USA Demand Cities:
New York, Los Angeles, Chicago, Houston, Miami, Dallas
π¬π§ UK Demand Cities:
London, Birmingham, Manchester, Liverpool, Glasgow
π¦πͺ UAE Demand Cities:
Dubai, Abu Dhabi, Sharjah, Ajman
πΏπ¦ South Africa Demand Cities:
Johannesburg, Cape Town, Durban, Pretoria
π°πͺ Kenya Demand Cities:
Nairobi, Mombasa, Kisumu
π»π³ Vietnam Demand Cities:
Ho Chi Minh City, Hanoi, Da Nang
πΈπ¬ Singapore Demand Market:
Singapore City healthcare distributors, hospitals & pharmacies
Why Choose Cordium Pharmaceuticals Pvt Ltd?
β India-based pharmaceutical exporter
β Quality-focused supply solutions
β International documentation support
β Fast export coordination
β Hospital & distributor enquiries accepted
β Competitive global supply network
For Breztri Aerosphere Inhaler export enquiry, bulk requirement, distributor partnership:
π± WhatsApp: +91-9405117673
π§ Email: info@cordiumpharma.com